第一单位：
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.;Institute of Chinese MateriaMedica, Hunan Academy of Chinese Medicine, Changsha 410013, China.
作者：
Fei,Cheng [1]
;
Jianping,Wu [2]
;
Yan,Zhang [3]
;
Yuyan,Wang [2]
;
Guihua,Li [2]
;
Hongliang,Zeng [4]
;
Xiaoai,He [5]
;
Guiming,Deng [6]
;
Jianbin,Tan [7]
;
Hongping,Long [6]
;
Puhua,Zeng [4]
;
Yiheng,Liu [5]
;
Gangzhi,Zhu [5]
;
Zuhui,Chen [8]
;
Kangping,Xu [9]
作者单位：
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.;Institute of Chinese MateriaMedica, Hunan Academy of Chinese Medicine, Changsha 410013, China.
[1]
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.;Hunan QingYa Health Service Limited Company, Changsha 410083, China.
[2]
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
[3]
Institute of Chinese MateriaMedica, Hunan Academy of Chinese Medicine, Changsha 410013, China.
[4]
Haikou People's Hospital and Central South University, Xiangya School of Medicine Affiliated Haikou Hospital, Haikou 570208, China.
[5]
The First Hospital of Hunan University of Chinese Medicine, Changsha 410007, China.
[6]
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.;Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, China.
[7]
Hunan QingYa Health Service Limited Company, Changsha 410083, China.
[8]
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.;Hunan QingYa Health Service Limited Company, Changsha 410083, China.;The First Hospital of Hunan University of Chinese Medicine, Changsha 410007, China.;Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, China.
[9]
DOI
10.3390/molecules27196349
PMID
36234885
发布时间
2022-10-19
换一批
